| 000 | 01004 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514075127.0 | ||
| 264 | 0 | _c20031001 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a1368-5031 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPhillips, L S | |
| 245 | 0 | 0 |
_aNateglinide (Starlix): update on a new antidiabetic agent. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _c |
||
| 300 |
_a535-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood Glucose _xphysiology |
| 650 | 0 | 4 |
_aCyclohexanes _xpharmacokinetics |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xcomplications |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aNateglinide |
| 650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDunning, B E | |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 57 _gno. 6 _gp. 535-41 |
|
| 999 |
_c12692075 _d12692075 |
||